Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

ITF2357, a Novel Histone Deacetylase Inhibitor, Demonstrates Significant Apoptotic Activity Against Human Multiple Myeloma Cells.

Michael Kline, PhD, Kathleen A. Donovan, PhD, John A. Lust, MD, PhD

Blood (2007) 110 (11): 4791.

https://doi.org/10.1182/blood.V110.11.4791.4791

Published: 2007

Journal Articles

Gene Expression Profiling of Myeloma Cells at Diagnosis Can Predict Response to Therapy with Thalidomide and Dexamethasone Combination.

Shaji Kumar, MD, Philip R. Greipp, MD, Jessica Haug, MD, Michael Kline, PhD, Wee Joo Chng, Emily Blood, MS, Leif Bergsagel, MD, John A. Lust, MD, Morie A. Gertz, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD

Blood (2005) 106 (11): 508.

https://doi.org/10.1182/blood.V106.11.508.508

Published: 2005

Journal Articles

Identification of Genes Associated with Increased Bone Marrow Angiogenesis in Multiple Myeloma.

Michael Kline, PhD, S. Vincent Rajkumar, MD, Jessica Haug, Linda Wellik, John A. Lust, MD, PhD, Rafael Fonseca, MD, Philip R. Greipp, MD, Shaji Kumar, MD

Blood (2005) 106 (11): 5109.

https://doi.org/10.1182/blood.V106.11.5109.5109

Published: 2005

Journal Articles

Prognostic Value of Bone Marrow Angiogenesis in Newly Diagnosed Multiple Myeloma: A Comparison with Conventional Prognostic Factors.

Shaji Kumar, MD, Jessica L. Haug, Linda Wellik, Thomas E. Witzig, MD, John A. Lust, MD, Michael Kline, PhD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Morie A. Gertz, MD, Philip R. Greipp, MD, S. Vincent Rajkumar, MD

Blood (2005) 106 (11): 5111.

https://doi.org/10.1182/blood.V106.11.5111.5111

Published: 2005

Journal Articles

Comparison of Myeloma Cell Gene Expression Profiles Pre and Post Thalidomide - Dexamethasone Therapy Provides Insight into Potential Mechanisms.

Shaji Kumar, MD, Philip R. Greipp, MD, Jessica Haug, Michael Kline, PhD, Emily Blood, MS, Wee Joo Chng, John A. Lust, MD, Leif Bergsagel, MD, Morie A. Gertz, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD

Blood (2005) 106 (11): 3480.

https://doi.org/10.1182/blood.V106.11.3480.3480

Published: 2005

Journal Articles

AT-101, a Small Molecule Inhibitor of Bcl-2 Family Proteins, Has Significant In Vitro Activity in Multiple Myeloma.

Shaji Kumar, MD, Michael Kline, PhD, Terry Kimlinger, BA, Michael Timm, Jessica Haug, Philip R. Greipp, MD, Dajun Yang, MD, PhD, S. Vincent Rajkumar, MD

Blood (2005) 106 (11): 1581.

https://doi.org/10.1182/blood.V106.11.1581.1581

Published: 2005

Journal Articles

ABT-737, an Inhibitor of Bcl-2/Bcl-X L Proteins, Is Cytotoxic in Multiple Myeloma Cells.

Michael Kline, PhD, Terry Kimlinger, Michael Timm, Jessica Haug, John A. Lust, MD, PhD, S.Vincent Rajkumar, MD, Shaji Kumar

Blood (2005) 106 (11): 1589.

https://doi.org/10.1182/blood.V106.11.1589.1589

Published: 2005

Journal Articles

Comparison of Newly Diagnosed and Relapsed Refractory Multiple Myeloma Using Transcriptional Profiling of Myeloma Cells.

Shaji Kumar, MD, Philip R. Greipp, MD, Jessica L. Haug, Michael Kline, PhD, Wee Joo Chng, Emily Blood, MS, John A. Lust, MD, PhD, Leif Bergsagel, MD, Morie A. Gertz, MD, Rafael Fonseca, MD, S. Vincent Rajkumar, MD

Blood (2005) 106 (11): 1555.

https://doi.org/10.1182/blood.V106.11.1555.1555

Published: 2005

Journal Articles

Thymoglobulin (Polyclonal Rabbit Anti Thymocyte Globulin) Has In Vitro Activity in Multiple Myeloma.

Shaji Kumar, MD, Michael Timm, Terry Kimlinger, Michael Kline, PhD, Jessica L. Haug, S. Vincent Rajkumar, MD, Philip R. Greipp, MD

Blood (2005) 106 (11): 5190.

https://doi.org/10.1182/blood.V106.11.5190.5190

Published: 2005

Journal Articles

Stromal Cell IL-8 Production Is Increased in MM and May Impact Both Tumor Cells and the Microenvironment.

Michael Kline, PhD, Kathleen Donovan, PhD, Linda Wellik, Christopher Lust, Wendy Jin, Laurie Moon-Tasson, Shaji Kumar, MD, Thomas E. Witzig, MD, S. Vincent Rajkumar, MD, John A. Lust, MD, PhD

Blood (2005) 106 (11): 2508.

https://doi.org/10.1182/blood.V106.11.2508.2508

Published: 2005

NARROW

ITF2357, a Novel Histone Deacetylase Inhibitor, Demonstrates Significant Apoptotic Activity Against Human Multiple Myeloma Cells.

Gene Expression Profiling of Myeloma Cells at Diagnosis Can Predict Response to Therapy with Thalidomide and Dexamethasone Combination.

Identification of Genes Associated with Increased Bone Marrow Angiogenesis in Multiple Myeloma.

Prognostic Value of Bone Marrow Angiogenesis in Newly Diagnosed Multiple Myeloma: A Comparison with Conventional Prognostic Factors.

Comparison of Myeloma Cell Gene Expression Profiles Pre and Post Thalidomide - Dexamethasone Therapy Provides Insight into Potential Mechanisms.

AT-101, a Small Molecule Inhibitor of Bcl-2 Family Proteins, Has Significant In Vitro Activity in Multiple Myeloma.

ABT-737, an Inhibitor of Bcl-2/Bcl-X L Proteins, Is Cytotoxic in Multiple Myeloma Cells.

Comparison of Newly Diagnosed and Relapsed Refractory Multiple Myeloma Using Transcriptional Profiling of Myeloma Cells.

Thymoglobulin (Polyclonal Rabbit Anti Thymocyte Globulin) Has In Vitro Activity in Multiple Myeloma.

Stromal Cell IL-8 Production Is Increased in MM and May Impact Both Tumor Cells and the Microenvironment.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only